Confident characterization and identification of glucuronide metabolites using diagnostic fragments from electron activated dissociation (EAD)

Key Takeaways

• Personalized treatment strategies have advanced the management of lung cancer brain metastases, integrating targeted therapies and immunotherapies for improved patient outcomes.
• Stereotactic radiosurgery and whole-brain radiation therapy are evolving with novel systemic therapies, maintaining their importance in treatment plans.
• Multidisciplinary approaches are crucial for optimizing treatment, considering genetic mutations, patient performance status, and potential side effects.
• Ongoing research aims to refine strategies, focusing on improved survival and quality of life for patients with lung cancer brain metastases.